These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22521929)

  • 21. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
    Risum N
    Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy.
    Hosoda J; Ishikawa T; Matsushita K; Matsumoto K; Kimura Y; Miyamoto M; Ogawa H; Takamura T; Sugano T; Ishigami T; Uchino K; Kimura K; Umemura S
    J Cardiol; 2012 Oct; 60(4):301-5. PubMed ID: 22763383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure.
    Zaręba W
    Cardiol J; 2010; 17(6):543-8. PubMed ID: 21154255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
    Brenyo A; Barsheshet A; Rao M; Huang DT; Zareba W; McNitt S; Hall WJ; Peterson DR; Solomon SD; Moss AJ; Goldenberg I
    Circ Heart Fail; 2013 Sep; 6(5):998-1004. PubMed ID: 23801020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac resynchronization therapy: current trends and future directions.
    Jacob S; Bharadwaj AS; Panaich SS; Mathew A; Afonso L
    Minerva Cardioangiol; 2010 Dec; 58(6):717-29. PubMed ID: 21135811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac resynchronization therapy: who benefits?
    Chinitz JS; d'Avila A; Goldman M; Reddy V; Dukkipati S
    Ann Glob Health; 2014; 80(1):61-8. PubMed ID: 24751566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
    Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG
    JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic role of right ventricular function in left ventricular disease in the setting of cardiac resynchronization therapy.
    Abdirahman I; Haddad T; Dwivedi G
    Curr Opin Cardiol; 2014 Mar; 29(2):185-91. PubMed ID: 24406447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left atrial volume and the benefit of cardiac resynchronization therapy in the MADIT-CRT trial.
    Kuperstein R; Goldenberg I; Moss AJ; Solomon S; Bourgoun M; Shah A; McNitt S; Zareba W; Klempfner R
    Circ Heart Fail; 2014 Jan; 7(1):154-60. PubMed ID: 24347664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing cardiac resynchronization therapy in advanced heart failure.
    Mullens W; Tang WH
    Congest Heart Fail; 2011; 17(3):147-51. PubMed ID: 21609389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness of cardiac resynchronization therapy in Greece: an analysis based on the CArdiac REsychronization in Heart Failure trial.
    Maniadakis N; Ekman M; Calvert MJ; Freemantle N; Karamalis M; Vardas P
    Europace; 2011 Nov; 13(11):1597-603. PubMed ID: 21821852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiac resynchronization therapy with defibrillation capability: considerations on a not yet proven therapeutic superiority].
    Berisso MZ; Canonero D; Caruso D; Setti S; Domenicucci S
    G Ital Cardiol (Rome); 2010 Apr; 11(4):295-305. PubMed ID: 20677575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac resynchronization therapy: past, present, and future.
    Chatterjee NA; Singh JP
    Heart Fail Clin; 2015 Apr; 11(2):287-303. PubMed ID: 25834976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
    Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
    Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiac resynchronization therapy in women].
    Lunati M; Landolina M; Cipriani M; Rordorf R; Bisetti S; Campo C; Ghio S; Frigerio M
    G Ital Cardiol (Rome); 2012 May; 13(5 Suppl 1):31S-34S. PubMed ID: 23678532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac resynchronization therapy: expanding clinical indications and refining patient selection.
    Nery PB; Keren A; Birnie DH
    Curr Opin Cardiol; 2012 Mar; 27(2):137-42. PubMed ID: 22233979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.